Skip to main content
. 2014 Apr 23;289(24):16688–16698. doi: 10.1074/jbc.M114.563502

FIGURE 1.

FIGURE 1.

TK3 clone reactivity. A, preferential recognition of HLA-B*35:01+ lymphoblastoid cell line (LCL) cells by the TK3 CTL clone compared with HLA-B*35:08+ lymphoblastoid cells presenting the HPVG peptide. B, recognition of HPVG and three EBV variants of the epitopes by the TK3 clone using a cytotoxicity assay with HLA-B*35:08+-phytohemagglutinin blasts as target cells.